Search

In this paper, mesoporous nitrocellulose (NC)/graphene oxide (GO) composite aerogel is manufactured by a sol-gel method followed by supercritical carbon dioxide drying. The effects of GO on the microstructure, decomposition, and thermal conductivity are studied. The laser absorption, laser ignition property, and combustion performance of NC aerogel and NC/aerogel are also investigated. The results indicate that NC/GO aerogel is established by the combination of NC nano-fibers and GO sheets, and the aerogels are mesoporous with average pore size at 40 nm. Moreover, the thermal stability of aerogels is decreased by the nano-structure of NC, and the laser absorption is significantly increased by the nano-porous structure and the adoption of GO. In addition, the laser ignition and combustion efficiency are also greatly improved by the nano-porous aerogel structure and the incorporation of evenly uniformly dispersed GO sheets with high photothermal conversion efficiency and thermal conductivity. Laser ignition times reduced by 73.7% and 99.6% are obtained, and flame propagation rates up to 4.7 and 12.3 times are observed for NC aerogel and NC/5 wt. % GO aerogel, respectively. [ABSTRACT FROM AUTHOR]

Aims: We aimed to explore Yarrowia lipolytica carbonyl reductases as effective biocatalysts and to develop efficient asymmetric reduction systems for chiral alcohol synthesis. Methods and Results: Yarrowia lipolytica carbonyl reductase genes were obtained via homologous sequence amplification strategy. Two carbonyl reductases, YaCRI and YaCRII, were identified and characterized, and used to catalyse the conversion of 2‐hydroxyacetophenone (2‐HAP) to optically pure (S)‐1‐phenyl‐1,2‐ethanediol. Enzymatic assays revealed that YaCRI and YaCRII exhibited specific activities of 6·96 U mg−1 (99·8% e.e.) and 7·85 U mg−1 (99·9% e.e.), respectively, and showed moderate heat resistance at 40–50°C and acid tolerance at pH 5·0–6·0. An efficient whole‐cell two‐phase system was established using reductase‐expressing recombinant Escherichia coli. The conversion of 2‐HAP (20·0 g l−1) conversion with the solvent of dibutyl phthalate was approximately 70‐fold higher than in water. Furthermore, the two recombinant E. coli displayed biocatalyst activity and enantioselectivity towards several different carbonyl compounds, and E. coli BL21 (DE3)/pET‐28a‐yacrII showed a broad substrate spectrum. Conclusions: A new whole‐cell recombinant E. coli‐based bioreduction system for enantiopure alcohol synthesis with high enantioselectivity at high substrate concentrations was developed. Significance and Impact of the Study: We proposed a promising approach for the efficient preparation of enantiopure chiral alcohols. [ABSTRACT FROM AUTHOR]

Abstract: Trans‐4‐Hydroxy‐ l‐proline (trans‐Hyp) is a valuable chiral building block for the synthesis of pharmaceutical intermediates. Bioconversion of l‐proline using recombinant strain with proline‐4‐hydroxylase (P4H) is a preferred biocatalytic process in the economical production of trans‐Hyp. In this study, a recombinant E. coli overexpressing hydroxylase (P4H), γ‐glutamyl kinase and glutamate‐semialdehyde dehydrogenase (ProBA) genes were constructed by knocking out the key genes in the metabolism. These key genes contained putA encoding proline dehydrogenase (PutA) in the l‐proline metabolism and other catalytic enzyme genes, sucAB encoding α‐ketoglutarate dehydrogenase (SucAB), aceAK encoding isocitratelyase (AceA) and isocitrate dehydrogenase kinase/phosphatase (AceK) in the TCA cycle. This recombinant strain coupled the synthetic pathway of trans‐Hyp with TCA cycle of the host strain. It inhibited the consumption of l‐proline completely and promoted the accumulation of 2‐oxoglutarate (2‐OG) as a co‐substrate, which realized the highest conversion of glucose to trans‐Hyp. A fed‐batch strategy was designed, capable of producing 31·0 g l−1trans‐Hyp from glucose. It provided a theoretical basis for commercial conversion of glucose to trans‐Hyp. Significance and Impact of the Study:Trans‐4‐Hydroxy‐ l‐proline (trans‐Hyp) is a valuable chiral building block for the synthesis of pharmaceutical intermediates. Unsatisfactory microbial bioconversion resulted in a low yield of trans‐Hyp. In this study, we blocked the unwanted blunting pathways of host strain and make the cell growth couple with the trans‐Hyp synthesis from glucose. Finally, a recombinant Escherichia coli with short‐cut and efficient trans‐Hyp biosynthetic pathway was obtained. It provided a theoretical basis for commercial production of trans‐Hyp. [ABSTRACT FROM AUTHOR]

Trans-4-Hydroxy-l-proline (trans-Hyp) is a valuable chiral building block for the synthesis of pharmaceutical intermediates. Bioconversion of l-proline using recombinant strain with proline-4-hydroxylase (P4H) is a preferred biocatalytic process in the economical production of trans-Hyp. In this study, a recombinant E. coli overexpressing hydroxylase (P4H), γ-glutamyl kinase and glutamate-semialdehyde dehydrogenase (ProBA) genes were constructed by knocking out the key genes in the metabolism. These key genes contained putA encoding proline dehydrogenase (PutA) in the l-proline metabolism and other catalytic enzyme genes, sucAB encoding α-ketoglutarate dehydrogenase (SucAB), aceAK encoding isocitratelyase (AceA) and isocitrate dehydrogenase kinase/phosphatase (AceK) in the TCA cycle. This recombinant strain coupled the synthetic pathway of trans-Hyp with TCA cycle of the host strain. It inhibited the consumption of l-proline completely and promoted the accumulation of 2-oxoglutarate (2-OG) as a co-substrate, which realized the highest conversion of glucose to trans-Hyp. A fed-batch strategy was designed, capable of producing 31·0 g l -1 trans-Hyp from glucose. It provided a theoretical basis for commercial conversion of glucose to trans-Hyp., Significance and Impact of the Study: Trans-4-Hydroxy-l-proline (trans-Hyp) is a valuable chiral building block for the synthesis of pharmaceutical intermediates. Unsatisfactory microbial bioconversion resulted in a low yield of trans-Hyp. In this study, we blocked the unwanted blunting pathways of host strain and make the cell growth couple with the trans-Hyp synthesis from glucose. Finally, a recombinant Escherichia coli with short-cut and efficient trans-Hyp biosynthetic pathway was obtained. It provided a theoretical basis for commercial production of trans-Hyp., (© 2018 The Society for Applied Microbiology.)